| Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma KA Schalper, ME Rodriguez-Ruiz, R Diez-Valle, A López-Janeiro, ... Nature medicine 25 (3), 470-476, 2019 | 536 | 2019 |
| CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity Á Teijeira, S Garasa, M Gato, C Alfaro, I Migueliz, A Cirella, C de Andrea, ... Immunity 52 (5), 856-871. e8, 2020 | 473 | 2020 |
| Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy E Perez-Ruiz, L Minute, I Otano, M Alvarez, MC Ochoa, V Belsue, ... Nature 569 (7756), 428-432, 2019 | 359 | 2019 |
| Identification of LZTFL1 as a candidate effector gene at a COVID-19 risk locus DJ Downes, AR Cross, P Hua, N Roberts, R Schwessinger, AJ Cutler, ... Nature genetics 53 (11), 1606-1615, 2021 | 135 | 2021 |
| IL8, neutrophils, and NETs in a collusion against cancer immunity and immunotherapy A Teijeira, S Garasa, MC Ochoa, M Villalba, I Olivera, A Cirella, ... Clinical Cancer Research 27 (9), 2383-2393, 2021 | 127 | 2021 |
| Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients ME Rodriguez-Ruiz, JL Perez-Gracia, I Rodriguez, C Alfaro, C Oñate, ... Annals of Oncology 29 (5), 1312-1319, 2018 | 117 | 2018 |
| Oncolytic DNX-2401 virus for pediatric diffuse intrinsic pontine glioma J Gállego Pérez-Larraya, M Garcia-Moure, S Labiano, A Patiño-García, ... New England Journal of Medicine 386 (26), 2471-2481, 2022 | 111 | 2022 |
| Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma CE De Andrea, M Wiweger, F Prins, JVMG Bovée, S Romeo, ... Laboratory Investigation 90 (7), 1091-1101, 2010 | 97 | 2010 |
| Amylin as a potential link between type 2 diabetes and alzheimer disease I Martinez‐Valbuena, R Valenti‐Azcarate, I Amat‐Villegas, M Riverol, ... Annals of neurology 86 (4), 539-551, 2019 | 91 | 2019 |
| Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT CE de Andrea, CMA Reijnders, HM Kroon, D de Jong, PCW Hogendoorn, ... Oncogene 31 (9), 1095-1104, 2012 | 87 | 2012 |
| Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade D Ajona, S Ortiz-Espinosa, T Lozano, F Exposito, A Calvo, K Valencia, ... Nature Cancer 1 (1), 75-85, 2020 | 85 | 2020 |
| Small deletions but not methylation underlie CDKN2A/p16 loss of expression in conventional osteosarcoma AB Mohseny, C Tieken, PA van der Velden, K Szuhai, C de Andrea, ... Genes, Chromosomes and Cancer 49 (12), 1095-1103, 2010 | 73 | 2010 |
| Cytology smears in the era of molecular biomarkers in non–small cell lung cancer: doing more with less MD Lozano, JI Echeveste, M Abengozar, LD Mejias, MA Idoate, A Calvo, ... Archives of pathology & laboratory medicine 142 (3), 291-298, 2018 | 68 | 2018 |
| Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL‐8 CE de Andrea, MC Ochoa, M Villalba‐Esparza, Á Teijeira, KA Schalper, ... The Journal of Pathology 255 (2), 190-201, 2021 | 63 | 2021 |
| Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial F Nassiri, V Patil, LS Yefet, O Singh, J Liu, RMA Dang, TN Yamaguchi, ... Nature medicine 29 (6), 1370-1378, 2023 | 61 | 2023 |
| Consistency and reproducibility of next‐generation sequencing and other multigene mutational assays: a worldwide ring trial study on quantitative cytological molecular … U Malapelle, C Mayo‐de‐Las‐Casas, MA Molina‐Vila, R Rosell, S Savic, ... Cancer cytopathology 125 (8), 615-626, 2017 | 60 | 2017 |
| Topological tumor graphs: a graph-based spatial model to infer stromal recruitment for immunosuppression in melanoma histology H Failmezger, S Muralidhar, A Rullan, CE de Andrea, E Sahai, Y Yuan Cancer research 80 (5), 1199-1209, 2020 | 59 | 2020 |
| The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma AB Mohseny, Y Cai, M Kuijjer, W Xiao, B van den Akker, CE de Andrea, ... European journal of cancer 48 (18), 3429-3438, 2012 | 59 | 2012 |
| GNAS mutations are not detected in parosteal and low-grade central osteosarcomas C Salinas-Souza, C De Andrea, M Bihl, M Kovac, N Pillay, T Forshew, ... Modern Pathology 28 (10), 1336-1342, 2015 | 50 | 2015 |
| SRC family kinase (SFK) inhibitor dasatinib improves the antitumor activity of anti-PD-1 in NSCLC models by inhibiting Treg cell conversion and proliferation E Redin, I Garmendia, T Lozano, D Serrano, Y Senent, M Redrado, ... Journal for immunotherapy of cancer 9 (3), 2021 | 46 | 2021 |
